Healthcare - Biotechnology - NASDAQ - US
$ 4.41
-8.51 %
$ 235 M
Market Cap
-4.64
P/E
BALANCE SHEET
272 M
ASSETS
121 M
LIABILITIES
151 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
TScan Therapeutics, Inc.
| Current Assets | 194 M |
| Cash & Short-Term Investments | 192 M |
| Receivables | 0 |
| Other Current Assets | 2.19 M |
| Non-Current Assets | 77.9 M |
| Long-Term Investments | 0 |
| PP&E | 71.2 M |
| Other Non-Current Assets | 6.68 M |
| Current Liabilities | 29.8 M |
| Accounts Payable | 2.37 M |
| Short-Term Debt | 9.84 M |
| Other Current Liabilities | 17.6 M |
| Non-Current Liabilities | 91.5 M |
| Long-Term Debt | 85.8 M |
| Other Non-Current Liabilities | 5.62 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 133.4 | 120.0 | 161.4 | 34.8 | 41.8 |
| Short Term Investments | 58.7 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 2.2 | 4.1 | 8.5 | 1.7 | 0.6 |
| Total Current Assets | 194.2 | 120.0 | 165.7 | 36.4 | 42.4 |
| PP&E | 71.2 | 69.2 | 17.3 | 12.5 | 6.4 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 5.0 | 5.2 | 0.8 | 0.6 |
| Other Long Term Assets | 6.7 | 4.8 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 272.1 | 199.1 | 188.1 | 49.7 | 49.4 |
| LIABILITIES | |||||
| Accounts Payable | 2.4 | 2.9 | 1.8 | 2.9 | 1.0 |
| Short Term Debt | 9.8 | 7.4 | 3.3 | 1.4 | 0.4 |
| Other Current Liabilities | 7.5 | 3.2 | 4.9 | 2.5 | 0.9 |
| Total Current Liabilities | 29.8 | 17.3 | 21.3 | 17.4 | 2.4 |
| Long Term Debt | 85.8 | 82.3 | 4.4 | (53.7) | 4.4 |
| Deferred Tax Income | 0 | 0 | 0 | 59.7 | 0 |
| Other Liabilities | 0 | 49 K | 97 K | (59.4) | 59.7 |
| Total Liabilities | 121.3 | 99.7 | 27.3 | 92.2 | 66.5 |
| EQUITY | |||||
| Common Stock | 5 K | 3 K | 3 K | 1 K | 0 |
| Retained Earnings | (247.6) | (158.4) | (92.2) | (43.5) | (17.4) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | (188.1) | (59.7) | 0 |
| Total Equity | 150.9 | 99.4 | 160.8 | (42.5) | (17.1) |
| Total Liabilities and Equity | 272.1 | 199.1 | 188.1 | 49.7 | 49.4 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 65.6 | 24.0 | 23.9 | 24.9 | 24.9 |